It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for DexCom Inc. (DXCM) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.97, or 0.90%, to $108.26. The DexCom Inc. has recorded 147,359 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany.
DexCom Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of DexCom Inc. is $41.84B. A total of 3.5 million shares were traded on the day, compared to an average of 3.35M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, DXCM has seen 0 BUY and 9 SELL insider trades, representing the acquisition of 0 and the disposition of 12,998 shares. Over the last 12 months, there were 31 BUYs and 86 SELLs from insiders. Insiders purchased 472,544 shares during that period but sold 409,344.
In the most recent transaction, Dolan Matthew Vincent sold 56 shares of DXCM for 102.32 per share on Sep 01. After the transaction, the SVP Corporate Strategy-Develop now owns 33,569 company shares. In a previous transaction on Aug 23, Pacelli Steven Robert sold 411 shares at 107.03 per share. DXCM shares that EVP Managing Director Dexcom V owns now total 126,008.
Among the insiders who sold shares, Sylvain Jereme M disposed of 1,844 shares on Aug 22 at a per-share price of $104.38. This resulted in the EVP Chief Financial Officer holding 72,867 shares of DXCM after the transaction. In another insider transaction, Stern Sadie sold 392 shares at $110.71 per share on Aug 09. Company shares held by the EVP Chief Human Resources Offi now total 81,682.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for DXCM in the last 3 months, the mean price target is $148.02 with high estimates of $160.00 and low estimates of $130.00. In terms of 52-week highs and lows, DXCM has a high of $139.55 and a low of $78.94.
As of this writing, DXCM has an earnings estimate of $0.34 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $0.46 per share and a lower estimate of $0.26. The company reported an EPS of $0.17 in the last quarter, which was 13.30% higher than expectations of $0.15.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $1.82B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.43, while its Total Shareholder’s Equity was $2.25B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.76.